Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.0
Impact Factor 2025
1.5
CiteScore 2025
1.0
Impact Factor 2025
1.5
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Hydroxychloroquine-induced generalized myopathy in a patient with lupus tumidus: a case report

    Alice Verdelli, Daniela Massi, Vincenza Maio, Gabriele Cavazza, Alberto Corrà, Elena Biancamaria Mariotti, Lavinia Quintarelli, Valentina Ruffo Di Calabria, Cristina Aimo, Emiliano Antiga, Marzia Caproni
    17-10-2023
    https://doi.org/10.4081/dr.2023.9771
    668
    PDF: 617
    HTML: 57
  • The efficacy of apremilast in pemphigus: a systematic review of case reports

    Roudin H. Alhasawi, Esraa A. Shaheen, Noura M. Alshabanat, Reem Brashi, Walaa Abdu Ahmed, Shumukh H. Alqahtani, Ethar G. Alharbi, Mazin Aljabri
    07-05-2025
    https://doi.org/10.4081/dr.2025.10245
    1003
    PDF: 445
    SUPPLEMENTARY MATERIAL: 61
    HTML: 16
  • A case report of Hailey-Hailey disease treated with fractional carbon dioxide laser

    Zivile Gabdrafike, Monika Blazeviciute, Ugne Janonyte, Jurgita Makstiene, Skaidra Valiukeviciene
    21-04-2023
    https://doi.org/10.4081/dr.2023.9658
    1056
    PDF: 528
    HTML: 52
  • Dermatological insight as the key to diagnosing intestinal Behçet’s disease misdiagnosed as Crohn’s: a case report

    Caterina Mariarosaria Giorgio, Eugenia Veronica Di Brizzi, Gaetano Licata, Carmine Fiorentino, Giuseppe Argenziano, Luca Damiani
    04-02-2025
    https://doi.org/10.4081/dr.2025.10232
    546
    PDF: 355
    HTML: 20
  • Refractory pityriasis rubra pilaris treated with abrocitinib

    Filip Rob
    09-01-2025
    https://doi.org/10.4081/dr.2025.10105
    477
    PDF: 315
    HTML: 22
  • Efficacy of autologous serum therapy in positive and negative autologous serum skin test patients in chronic urticaria in a tertiary care centre

    Raghavendra KR, Bangaru H
    06-07-2022
    https://doi.org/10.4081/dr.2022.9525
    2166
    PDF: 588
    HTML: 72
  • Treatment and follow-up of genital lichen sclerosus in male children: multidisciplinary management at a tertiary care center

    Alessia Paganelli, Paolo Viscardo Fabbri, Filippo Ghidini, Laura Bigi, Claudia Lasagni, Pier Luca Ceccarelli
    09-08-2023
    https://doi.org/10.4081/dr.2023.9774
    627
    PDF: 337
    Supplementary Material: 129
    HTML: 516
  • Wegener´s granulomatosis in a young patient preceded by localized cutaneous manifestations

    Jesper Smit, Jakob Lykke Poulsen, Jakob Sølling, Carsten Sauer Mikkelsen
    e44
    27-10-2011
    https://doi.org/10.4081/dr.2011.e44
    1589
    PDF: 567
    HTML: 1601
  • Resolution of paraneoplastic palmoplantar keratoderma after treating mixed serous neuroendocrine tumor of the pancreas: a case report and literature review

    Hend M. Alotaibi, Abdulrahman Alluhaybi, Khalid Nabil Nagshabandi, Maha M. Barakeh
    06-02-2024
    https://doi.org/10.4081/dr.2024.9906
    1476
    PDF: 618
    HTML: 50
  • 4th National Congress of the Bulgarian Society for Dermatologic Surgery, Sofia, 12th March 2022 with main topics: one step melanoma surgery and drug induced melanoma

    Georgi Tchernev, Nikhil Oliveira, Lorraine Joseph Kandathil, James W. Patterson, Jose Carlos Cardoso, Simona Kordeva, Ivan Pidakev, Konstantin Stavrov
    23-11-2022
    https://doi.org/10.4081/dr.2022.9542
    869
    PDF: 343
    HTML: 25
  • Successful treatment of refractory generalized granuloma annulare with abrocitinib

    Caterina Mariarosaria Giorgio, Anna Balato, Gaetano Licata, Vittorio Tancredi, Giuseppe Argenziano, Eugenia Veronica Di Brizzi
    23-01-2026
    https://doi.org/10.4081/dr.2026.10296
    439
    PDF: 273
  • Diffuse cutaneous mastocytosis masquerading as linear IgA bullous dermatosis of childhood

    Tuntas Rayinda, Dyah Ayu Mira Oktarina, Retno Danarti
    17-03-2021
    https://doi.org/10.4081/dr.2021.9021
    3982
    PDF: 774
    HTML: 42
  • Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: a systematic review of therapeutic outcomes and complications

    Vasiliki Tasouli-Drakou, May Nguyen, Hannah Guinn, Omron Hassan, Sneha Butala, Sheshanna Phan
    21-11-2022
    https://doi.org/10.4081/dr.2022.9492
    1797
    PDF: 696
    HTML: 91
1 - 13 of 13 items

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • XXXI Congresso Nazionale Intergruppo Melanoma Italiano (IMI)
    • IMI - Epidemiology, genetics and pathogenesis
    • IMI - Prevention and diagnosis
    • IMI - Pathological and molecular classification
    • IMI - Surgery
    • IMI - Therapy
    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.